Close Menu

This article has been updated from a previous version to include comments from Trovagene's Q3 earnings call.

NEW YORK (GenomeWeb) – Trovagene reported after the close of the market on Monday flat year-over-year third quarter revenues as it trimmed its net loss in half.

For the three months ended Sept. 30, 2015, the San Diego-based molecular diagnostics developer reported $57,000 in revenues. The company reported $51,000 in royalty revenue compared to $57,000 a year ago, and $6,000 in diagnostic service revenue compared to none in Q3 2014.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A man has confessed to the rape and murder of developmental biologist Suzanne Eaton, according to the New York Times.

The Irish Times reports that US lawmakers and law enforcement agencies are concerned about ties between the US and Chinese genomics firms.

Parents of children with spinal muscular atrophy tell the Washington Post they are pushing to get insurance coverage of Novartis's Zolgensma.

In PNAS this week: gene mutations in individuals with syndromic craniosynostosis, putative colorectal cancer drivers, and more.